Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jan 7, 2022; 10(1): 79-90
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.79
Table 2 Distribution and comparison of transient receptor potential vanilloid-1 in antrum cells in the morbidly obese and control groups, n (%)
Antrum
Obese
Control
All cases
P value
FoveolarNo staining14 (30.4)7 (35)21 (31.8)
DistributionLimited10 (21.7)1 (5)11 (16.6)
Widespread22 (47.8)12 (60)34 (51.5)
IntensityPoor27 (58.6)10 (50)37 (56.0)
Strong5 (10.8)3 (15)8 (12.1%)
IRS ± SE5.18 ± 0.59a4.35 ± 0.91a4.92 ± 0.49a0.44
MucousNo staining20 (43.4)9 (45)29 (43.9)
DistributionLimited21 (45.6)7 (35)28 (42.4)
Widespread5 (10.8)4 (20)9 (13.6)
IntensityPoor19 (41.3)8 (40)27 (40.9)
Strong7 (15.2)3 (15)10 (15.1)
IRS ± SE3.24 ± 0.60a2.30 ± 0.70a2.95 ± 0.46a0.56